Related Experiment Video
Updated: Jun 13, 2026

05:58
Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
Published on: September 11, 2013
A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection
Takayuki Baba1, Imran A Bhutto, Carol Merges
1Wilmer Ophthalmological Institute, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21287, USA.
The American Journal of Pathology
|April 17, 2010
Summary
Researchers developed a new rat model for choroidal neovascularization (CNV) using 13(S)-hydroperoxy-9Z,11E-octadecadienoic acid (HpODE). This model closely mimics CNV in age-related macular degeneration and is suitable for testing new therapies.
Area of Science:
- Ophthalmology
- Neovascularization research
- Animal modeling
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision loss.
- Choroidal neovascularization (CNV) is a key pathological feature of wet AMD.
- 13(S)-hydroperoxy-9Z,11E-octadecadienoic acid (HpODE), found in aged human Bruch's membrane, induces neovascularization.
Purpose of the Study:
- To develop and characterize a rat model of CNV.
- To assess the relevance of HpODE in inducing CNV.
- To establish a reproducible model for AMD research.
Main Methods:
- Subretinal injection of HpODE in Sprague-Dawley rats.
- Fluorescein angiography for leakage assessment.
- Histological and immunohistochemical analyses for CNV quantification.
- In vitro assays with various cell types to test HpODE effects.
Main Results:
- HpODE induced CNV in 85.7% of injected eyes.
- Neovascular areas were significantly larger in HpODE-treated eyes compared to controls (P=0.023).
- CNV showed peak leakage at 3 weeks, subsiding by 5 weeks, with macrophage infiltration observed.
- In vitro, low concentrations of HpODE promoted endothelial cell proliferation and migration.
Conclusions:
- The HpODE-induced rat model is a reproducible and relevant experimental system for studying CNV in AMD.
- This model's natural course is suitable for evaluating therapeutic interventions for AMD.
- HpODE's role in AMD pathogenesis is further supported by its efficacy in inducing CNV in this model.

